Richard Rubino | CFO & Secretary |
Vincente Anido | Chairman & CEO |
Thomas Mitro | President & COO |
Adnan Butt | Guggenheim Securities |
Andrew Santos | Stifel, Nicolaus & Company |
Dewey Steadman | Canaccord Genuity Limited |
Serge Belanger | Needham & Company |
Difei Yang | Mizuho Securities |
Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Aerie Pharmaceuticals First Quarter 2018 Earnings conference call. [Operator Instructions]. It is now my pleasure to turn the floor over to Aerie's Chief Financial Officer, Rich Rubino. Please go ahead sir.